Kalshi Loses New York Ruling: Federal License Does Not Override State Gambling Law
US District Judge Analisa Torres of the Southern District of New York denied Kalshi's motion for a preliminary injunction on July 7, ruling that the Commodity Exchange Act does not preempt New York's gambling enforcement. The decision — Kalshi's own suit, not the CFTC's — hands state regulators another win and opens a second federal circuit on prediction market law. Kalshi appealed to the Second Circuit the same day.
US District Judge Analisa Torres of the Southern District of New York denied Kalshi's motion for a preliminary injunction on July 7, 2026, in KalshiEX LLC v. Williams — Kalshi's own suit against New York officials, filed in October 2025 after the state sent a cease-and-desist letter alleging it was offering sports gambling without a New York license. Torres ruled that the Commodity Exchange Act does not preempt New York's gambling enforcement under either field preemption or conflict preemption theory. Kalshi filed notice of appeal to the US Court of Appeals for the Second Circuit the same day.
The ruling adds a third datapoint against the platforms' central legal argument. In Arizona, the CFTC won a preliminary injunction on May 5 based on three distinct preemption theories: field preemption, conflict preemption, and impossibility. Torres rejected all three in New York. She held that the CEA does not occupy the entire regulatory field for event contracts to the exclusion of state law. She rejected conflict preemption on the grounds that Kalshi can simultaneously comply with its CFTC obligations and New York's gambling law — by either obtaining a state gambling license or limiting which contracts it offers to New York residents. And impossibility preemption failed for the same reason: compliance with both regimes is possible, just commercially inconvenient. The CFTC filed its own separate suit against New York in May 2026, which remains pending in a parallel docket.
New York is the largest legal sports-betting market in the United States, generating roughly $2.3 billion in annual handle through the licensed online system overseen by the New York State Gaming Commission. That context shapes how state regulators view an unlicensed federal exchange offering the same sports-outcome contracts: not as a different product, but as unlicensed competition for the same dollar. The Torres ruling means the New York Gaming Commission can now proceed with enforcement against Kalshi and other prediction market platforms without a federal injunction blocking it.
Prediction-market preemption is now active in three federal appellate jurisdictions simultaneously. The Sixth Circuit has the Michigan case, where Polymarket and Robinhood's preliminary injunction was denied in June. The Ninth Circuit has the Arizona case, where the CFTC won its injunction in May and an appeal from Arizona is expected. And now the Second Circuit has the New York case, where Kalshi's own injunction was denied July 7. The three-circuit split makes a Supreme Court resolution increasingly likely. The question is whether any circuit moves fast enough to settle the question before the August 1 Minnesota felony ban goes live or before Congress passes a federal prediction-market bill that would resolve the jurisdiction question by statute.
Operators mentioned in this article
Recent updates
Prediction Markets Hit Wall Street Earnings Season: DraftKings at $11B Annualized Volume, Robinhood at $156M Revenue, Coinbase at $100M+
Prediction markets featured prominently in Q2 2026 earnings reports from DraftKings, Robinhood, Coinbase, and Flutter. DraftKings' prediction platform grew from $2.3 billion to $11 billion in annualized volume between April and July, with CEO Jason Robins expecting 'millions' of users by NFL season. Robinhood's Rothera generated $156 million in event contracts revenue in its first partial quarter. Coinbase reported 106% quarter-over-quarter growth in prediction market revenue, surpassing $100 million annualized. Flutter is moving FanDuel Predicts from CME to Crypto.com ahead of the NFL season.
Kalshi and Polymarket Are Now Taking Bets on Clinical Trials. Researchers Say That Is a Structural Integrity Problem.
Kalshi and Polymarket have begun allowing users to bet on the outcomes of clinical drug trials and FDA approval decisions. Researchers running those trials say the markets create direct financial incentives for people with access to trial data — pharmacists, coordinators, investigators — to tamper with results. Kalshi argues the markets are no different from stock market short sellers and will provide valuable information about drug development. Critics call the whole thing 'ghastly.' The debate represents the most ethically serious challenge prediction markets have faced.
Polymarket Becomes the ATP Tour's Official Prediction Market Provider — With Sportradar Supplying Integrity Monitoring
Polymarket has signed a deal with Tennis Data Innovations, the joint venture between the ATP Tour and ATP Media Holdings, to become the tour's official prediction market provider. The agreement covers approximately 20,000 matches per season across the ATP Tour and ATP Challenger Tour, with official live data and odds supplied by Sportradar — which will also provide integrity monitoring services. US users will get integrated live streaming alongside real-time prediction market contracts. It is Polymarket's second major data and streaming partnership in two days, following the Genius Sports deal on August 5.